EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Riboflavin Metabolism Links Metabolic State to Biofilm Development, Cell‐Envelope Homeostasis, and Antimicrobial Susceptibility in Mycobacterium tuberculosis

Anannya Dhanwal iD, Vaishnavi Tripathi iD, Saptarshi Sengupta iD, Linus Augustin iD, Manish Bansal iD, Sheetal Gandotra iD, Nisheeth Agarwal iD, Ruchi Jain Dey iD

Microbial Biotechnology · 2026-11 · 19 (11)

DOI: 10.1111/1751-7915.70461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Biotechnology, online erschienen am 09.11.2026. Verfasst von Anannya Dhanwal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Birla Institute of Technology and Science Pilani, Hyderabad Campus, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Biofilms, Mycobacterium tuberculosis, Riboflavin, Cell Membrane. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm formation and phenotypic drug tolerance contribute to the persistence and treatment challenges associated with Mycobacterium tuberculosis ( M. tb ). Although M. tb lacks canonical quorum‐sensing systems, it exhibits coordinated metabolic and cell‐envelope adaptations during biofilm development, suggesting the existence of alternative mechanisms linking cellular metabolism to multicellular behaviour. Here, using a combination of functional genomics, metabolic perturbation and systems‐level analyses, we identify riboflavin metabolism as a regulatory axis influencing biofilm development and antimicrobial susceptibility in M. tb . CRISPRi‐mediated knockdown and targeted overexpression of riboflavin biosynthetic genes markedly altered biofilm architecture, cell morphology, envelope ultrastructure, membrane permeability and lipid composition, with ribA2 and ribF emerging as potential metabolic vulnerabilities. Exogenous riboflavin enhanced biofilm formation, whereas the riboflavin antimetabolite roseoflavin suppressed this phenotype. Notably, cell‐free supernatants from late‐stage cultures, accumulated higher levels of riboflavin and restored biofilm formation in a riboflavin‐biosynthesis‐deficient strain, supporting a diffusible regulatory function beyond the established metabolic roles of riboflavin‐derived FMN and FAD. Integrated transcriptomic and lipidomic analyses revealed coordinated reprogramming of biofilm‐associated regulatory pathways, cell‐envelope lipid metabolism and the F 420 biosynthetic network, accompanied by increased susceptibility to anti‐tuberculosis drugs. Molecular docking further identified potential interactions of riboflavin with regulatory proteins associated with biofilm and stress‐response pathways. Together, these findings establish riboflavin metabolism as a previously underappreciated regulatory layer connecting microbial metabolism, biofilm development, cell‐envelope homeostasis and drug tolerance. This metabolic axis provides a potential framework for developing microbial biotechnology‐based strategies to interfere with biofilm‐associated persistence and improve the efficacy of anti‐tuberculosis therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsMycobacterium tuberculosisRiboflavinCell MembraneCell WallHomeostasisAntitubercular AgentsMicrobial Sensitivity TestsGene Expression Regulation, Bacterial

Stichwörter der Autor:innen

Mycobacterium tuberculosisantimicrobial susceptibilityanti‐tuberculosis drugsbiofilmdrug tolerancefunctional genomicsmetabolic engineering CRISPRinon‐canonical microbial signallingriboflavin metabolismsystems biology

Substanzen

RiboflavinAntitubercular Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, Birla Institute of Technology and Science Pilani, Hyderabad Campus, Hyderabad, Telangana, India.
  • CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • Translational Health Science and Technology Institute, Faridabad, Haryana, India.

ORCID-Profile: Anannya Dhanwal, Vaishnavi Tripathi, Saptarshi Sengupta, Linus Augustin, Manish Bansal, Sheetal Gandotra, Nisheeth Agarwal, Ruchi Jain Dey

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • Council of Scientific and Industrial Research, India

Zitieren

APA

Dhanwal, A., Tripathi, V., Sengupta, S., Augustin, L., Bansal, M., Gandotra, S., Agarwal, N., & Dey, R. J. (2026). Riboflavin Metabolism Links Metabolic State to Biofilm Development, Cell‐Envelope Homeostasis, and Antimicrobial Susceptibility in Mycobacterium tuberculosis. Microbial Biotechnology, 19(11). https://doi.org/10.1111/1751-7915.70461

Vancouver

Dhanwal A, Tripathi V, Sengupta S, Augustin L, Bansal M, Gandotra S, et al. Riboflavin Metabolism Links Metabolic State to Biofilm Development, Cell‐Envelope Homeostasis, and Antimicrobial Susceptibility in Mycobacterium tuberculosis. Microbial Biotechnology. 2026;19(11). doi:10.1111/1751-7915.70461

BibTeX
@article{Dhanwal2026,
  author = {Dhanwal, Anannya and Tripathi, Vaishnavi and Sengupta, Saptarshi and Augustin, Linus and Bansal, Manish and Gandotra, Sheetal and Agarwal, Nisheeth and Dey, Ruchi Jain},
  title = {Riboflavin Metabolism Links Metabolic State to Biofilm Development, Cell‐Envelope Homeostasis, and Antimicrobial Susceptibility in Mycobacterium tuberculosis},
  journal = {Microbial Biotechnology},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1111/1751-7915.70461}
}
Kostenlos starten →